Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 17/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6204428 | 0.88 | GSK3B (0.40) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL5098926 | 0.84 | GSK3B (0.46) | GSK3BCYP2D6CYP1A2ADRA1DADRA1A | |
| SCHEMBL5095450 | 0.83 | GSK3B (0.45) | GSK3BCYP2D6CYP1A2ADRA1DADRA1A | |
| SCHEMBL5095329 | 0.81 | GSK3B (0.42) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL5095337 | 0.81 | GSK3B (0.42) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL6201903 | 0.79 | GSK3B (0.40) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL6203575 | 0.79 | GSK3B (0.40) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL5109413 | 0.79 | GSK3B (0.46) | GSK3BCYP2D6CYP1A2ADRA1DADRA1A | |
| SCHEMBL3564878 | 0.78 | GSK3B (0.47) | GSK3BCYP2D6CYP1A2CYP3A4 | |
| Oxalic Acid SCHEMBL5098928 | 0.78 | GSK3B (0.39) | GSK3BCYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1480983-A1 | HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYDIMIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES | Sanofi-Aventis (FR) | 2004-12-01 | — | — | EP | claimed |
| WO-2003072579-A1 | HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES | SANOFI-AVENTIS (FR) | 2003-09-04 | — | — | WO | claimed |
| EP-1480983-A1 | HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL-6,7,8,9-TETRAHYDROPYDIMIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES | Sanofi-Aventis (FR) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003072579-A1 | HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES | SANOFI-AVENTIS (FR) | 2003-09-04 | — | — | WO | disclosed |